NIST Partners With the Gates Foundation to Develop Breathalyzers for Malaria and Tuberculosis

nist

View as a Web Page

News

NIST Partners With the Gates Foundation to Develop Breathalyzers for Malaria and Tuberculosis

Illustration shows a breathalyzer device with a paper report and microscope slides.

The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) has signed a cooperative research and development agreement (CRADA) with the Bill & Melinda Gates Foundation to begin creating standards and testing protocols for a new generation of breathalyzers that can diagnose malaria and tuberculosis (TB).

Under the CRADA, NIST researchers will launch a new effort to develop tools and techniques for ensuring that the breathalyzers are accurate and reliable, which will be vital should they come to market and be deployed throughout the developing world.

Read More

IN CASE YOU MISSED IT

Illustration shows parts of the frequency comb breathalyzer system and the "fingerprint" of methanol.

JILA’s Comb Breathalyzer Is Now a Thousandfold More Sensitive to Disease Biomarkers

Oct. 4, 2021
When validated and engineered into a portable design, the comb system could offer real-time, noninvasive analysis of human breath to detect and monitor diseases.

Read More